Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 07, 2026
Why Is Post Holdings (POST) Stock Down -10.62% Today?

Why Is Post Holdings (POST) Stock Down -10.62% Today?

Key Takeaways

  • Post Holdings shares plunged 10.62% to $80.65 in Friday morning trading, following the release of disappointing fiscal third-quarter 2026 results after Thursday's closing bell.
  • The primary catalyst was a significant revenue miss — $1.94 billion versus the $2.03 billion consensus — coupled with a 41.7% year-over-year decline in net earnings.
  • Persistent weakness in the company's core cereal and pet food categories, along with compressed gross margins and rising operating expenses, fueled investor concern about the growth trajectory.
  • The sell-off accelerated after management narrowed its full-year adjusted EBITDA guidance range, signaling caution amid ongoing volume pressures and mid-single-digit input-cost inflation.
  • The stock broke decisively below its prior 52-week low of $83.89 on heavy volume, with traders now watching for any further analyst downgrades or price-target cuts.

Opening Summary

POST, the consumer packaged goods holding company behind brands such as Honey Bunches of Oats, Pebbles, Peter Pan peanut butter, Rachael Ray Nutrish pet food, Michael Foods, and Bob Evans Farms, saw its shares tumble 10.62% on Friday. The stock traded at $80.65 as of mid-morning, down from Thursday's closing price of $90.23, after the company reported fiscal third-quarter results that missed Wall Street's revenue estimates and revealed a sharp contraction in profitability. While adjusted earnings per share of $1.78 edged past the $1.72 consensus, a $90 million top-line shortfall and a 41.7% plunge in net earnings dominated the market's reaction.

Q3 Earnings: Revenue Miss Overshadows EPS Beat

Post Holdings reported net sales of $1.948 billion for the quarter ended June 30, 2026 — a 1.8% decline from $1.984 billion a year earlier and notably below the $2.03 billion analysts had projected. The revenue shortfall was broad-based, reflecting softening volumes across the company's Post Consumer Brands segment, where both ready-to-eat cereal and pet food categories continued to face demand headwinds. Tracked-channel data had pointed to cereal category declines of approximately 3% and dry dog food volume erosion of around 4%, trends that worsened rather than improved in the third quarter despite management's earlier expectations of a second-half recovery.

The bottom line deteriorated far more sharply than the top line. Operating profit fell 19.3% year-over-year to $189.3 million, while net earnings attributable to common shareholders collapsed 41.7% to $63.4 million, or $1.29 per diluted share on a GAAP basis. Gross margin compressed to 29.1% of net sales from 30.0% a year ago, squeezed by mid-single-digit input-cost inflation that the company has so far largely absorbed rather than passed through to consumers. Selling, general, and administrative expenses also climbed, while interest expense jumped to $108.2 million from $88.5 million, reflecting the company's elevated debt load of approximately $7.6 billion in long-term borrowings.

Guidance Narrowed, Confidence Shaken

In tandem with the quarterly report, Post Holdings narrowed its fiscal 2026 adjusted EBITDA outlook to a range of $1.56 billion to $1.57 billion, from the prior $1.55 billion to $1.58 billion. While the midpoint was essentially unchanged, the narrowing was interpreted by the market as a signal that management sees limited upside scenarios for the remainder of the year. The company cited ongoing geopolitical uncertainty, higher fuel and diesel surcharge costs, and persistent category softness in pet food and cereal as factors restraining the outlook. Management indicated it would continue absorbing incremental costs through the balance of the fiscal year but may pursue targeted pricing actions in fiscal 2027 if inflationary pressures do not abate.

Pet Food and Cereal Weakness in Focus

The core of Post's center-of-the-store business — branded and private-label cereals, along with its pet food portfolio anchored by Rachael Ray Nutrish, 9Lives, and Kibbles 'n Bits — has been under scrutiny for several quarters. The Nutrish brand relaunch, which management previously highlighted as a catalyst for stabilization, is now expected to take the entirety of the third quarter to reach full shelf deployment, with meaningful volume improvement pushed into the fiscal fourth quarter. Investors appeared skeptical that the timeline will hold, particularly as broader consumer trade-down behavior and private-label competition intensify in both the cereal and pet food aisles. Jefferies analyst Scott Marks had flagged in late July that tracked-channel data showed "cereal softening and pet food pressures persisting rather than the expected H2 improvement," a warning that proved prescient.

Market Context and Trading Activity

The magnitude of Friday's decline — over 10% — placed POST among the worst-performing names in the consumer staples sector. Trading volume surged well above the daily average of approximately 866,000 shares, indicating heavy institutional repositioning following the earnings release and morning conference call. The stock sliced through its prior 52-week low of $83.89, a level that had provided a floor during the August 5 session, and also broke below both its 50-day and 200-day simple moving averages of roughly $90 and $98, respectively. Broader equity indices were relatively stable, underscoring that the sell-off was stock-specific rather than macro-driven. The consumer staples sector has faced headwinds this year as investors rotated toward growth-oriented names, but Post's earnings-driven plunge was an idiosyncratic event.

Heading into the print, sell-side sentiment had already been cooling. In the weeks before earnings, Barclays lowered its price target from $119 to $106, JPMorgan trimmed its target from $119 to $116, Wells Fargo cut from $110 to $98, and Evercore ISI made a modest reduction from $131 to $128. All four firms maintained their constructive ratings, but the pattern of consistent target cuts signaled growing unease about near-term execution. With shares now trading below even the lowest Street target of $98, further revisions may be forthcoming.

What Comes Next for POST

The immediate focus shifts to whether the Nutrish relaunch and other brand-remediation efforts can deliver the promised fourth-quarter inflection in pet food volumes, and whether cereal category trends stabilize as the company cycles easier year-ago comparisons. Investors will also monitor management's commentary on pricing strategy, particularly if mid-single-digit inflation persists into fiscal 2027. On the capital-allocation front, Post's aggressive share repurchase program — which reduced the share count by roughly 15% year-to-date through $917 million in buybacks — has provided some support to per-share metrics but has also drawn attention to the company's elevated leverage. With net debt to adjusted EBITDA running above 4.5x, the balance sheet remains a point of debate among credit-focused investors. The next major catalyst will be the fiscal fourth-quarter report, where the market will look for tangible evidence that the company's brand investments and cost-containment measures are gaining traction.

Trending AI Robots

For traders seeking automated strategies in volatile markets like consumer staples, Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers. Only the strongest performers under current market conditions are featured in the curated Trending AI Robots section, where bots are evaluated by strategy, timeframe, performance metrics, and traded symbols. Whether you are looking to navigate earnings-driven swings or identify longer-term trend opportunities, exploring Tickeron's AI trading tools can provide a data-driven edge in your decision-making process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: POST

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


POST in downward trend: price dove below 50-day moving average on August 07, 2026

POST moved below its 50-day moving average on August 07, 2026 date and that indicates a change from an upward trend to a downward trend. In of 53 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 07, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on POST as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for POST turned negative on August 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where POST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for POST entered a downward trend on July 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for POST's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for POST crossed bullishly above the 50-day moving average on July 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where POST advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

POST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.159) is normal, around the industry mean (5.000). P/E Ratio (14.307) is within average values for comparable stocks, (36.456). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.974). POST has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.054). P/S Ratio (0.525) is also within normal values, averaging (8.092).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. POST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

Notable companies

The most notable companies in this group are Kraft Heinz Company (The) (NASDAQ:KHC), General Mills (NYSE:GIS), The Campbell's Company (NASDAQ:CPB), Beyond Meat (NASDAQ:BYND).

Industry description

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

Market Cap

The average market capitalization across the Food: Major Diversified Industry is 3.26B. The market cap for tickers in the group ranges from 68.52K to 255.67B. NSRGY holds the highest valuation in this group at 255.67B. The lowest valued company is THRC at 68.52K.

High and low price notable news

The average weekly price growth across all stocks in the Food: Major Diversified Industry was 3%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was -9%. WYHG experienced the highest price growth at 153%, while USNA experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Food: Major Diversified Industry was 57%. For the same stocks of the Industry, the average monthly volume growth was 50% and the average quarterly volume growth was 9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 63
Price Growth Rating: 58
SMR Rating: 79
Profit Risk Rating: 91
Seasonality Score: -18 (-100 ... +100)
View a ticker or compare two or three
POST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of branded ready-to-eat cereals

Industry FoodMajorDiversified

Profile
Details
Industry
Food Specialty Or Candy
Address
2503 South Hanley Road
Phone
+1 314 644-7600
Employees
11430
Web
https://www.postholdings.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.